retatrutide weight loss retatrutide clinical trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v retatrutide phase 2 trial results

The Ozempic Dilemma: Rationing Amidst Rising Demand Ozempic, a product of Novo Nordisk, is at the center of an unfolding medical and supply chain conundrum

(Some retailers circumvent these regulations and safety reviews, citing that the sale of these peptides is for research purposes or simply by using non-regulated, non-accredited pharmacies altogetherboth of which are red-flag practices that raise concerns about their overall safety practices.) Is GHK-Cu worth the hype

The new state hub focuses on the two claim categories that hit Texas Latinos EDsmart Ranks California's Best Colleges for 2026

Lower strength often requires longer usage to achieve similar effects

Cagrilintide (NNC0174-0833) is a long-acting, acylated amylin analogue developed by Novo Nordisk